MINERVINI, CRESCENZIO FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 4.329
EU - Europa 2.176
AS - Asia 1.728
SA - Sud America 405
AF - Africa 108
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.750
Nazione #
US - Stati Uniti d'America 4.228
SG - Singapore 681
DE - Germania 600
IT - Italia 528
CN - Cina 402
BR - Brasile 316
RU - Federazione Russa 298
SE - Svezia 191
HK - Hong Kong 177
GB - Regno Unito 152
FI - Finlandia 124
VN - Vietnam 123
FR - Francia 113
IN - India 71
BD - Bangladesh 58
CA - Canada 53
CI - Costa d'Avorio 47
ID - Indonesia 31
ZA - Sudafrica 30
MX - Messico 29
PK - Pakistan 29
AR - Argentina 26
IQ - Iraq 26
PL - Polonia 23
BE - Belgio 22
UA - Ucraina 22
TR - Turchia 19
CO - Colombia 17
CZ - Repubblica Ceca 17
JP - Giappone 15
NL - Olanda 15
PH - Filippine 15
VE - Venezuela 15
CL - Cile 14
ES - Italia 11
AT - Austria 10
IE - Irlanda 9
NP - Nepal 9
TN - Tunisia 9
UZ - Uzbekistan 9
SA - Arabia Saudita 8
LT - Lituania 7
MA - Marocco 7
MY - Malesia 7
EC - Ecuador 6
KZ - Kazakistan 6
PE - Perù 6
PS - Palestinian Territory 6
EG - Egitto 5
IR - Iran 5
PT - Portogallo 5
AZ - Azerbaigian 4
IL - Israele 4
LB - Libano 4
PA - Panama 4
RO - Romania 4
RS - Serbia 4
AL - Albania 3
AU - Australia 3
CH - Svizzera 3
CR - Costa Rica 3
GR - Grecia 3
HN - Honduras 3
HR - Croazia 3
JM - Giamaica 3
KE - Kenya 3
PY - Paraguay 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
ET - Etiopia 2
HU - Ungheria 2
KG - Kirghizistan 2
KR - Corea 2
OM - Oman 2
QA - Qatar 2
SV - El Salvador 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GN - Guinea 1
HT - Haiti 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
NA - Namibia 1
NI - Nicaragua 1
SI - Slovenia 1
SO - Somalia 1
TL - Timor Orientale 1
TW - Taiwan 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 8.750
Città #
Ashburn 517
Fairfield 451
Singapore 389
Chandler 310
San Jose 265
Woodbridge 253
Houston 207
Seattle 187
Hong Kong 175
Nyköping 164
Cambridge 161
Beijing 153
New York 151
Milan 144
Wilmington 139
Ann Arbor 112
Munich 103
Los Angeles 101
Helsinki 68
Bari 58
Rome 55
Lauterbourg 53
Falkenstein 48
Abidjan 47
Jacksonville 44
Lawrence 43
Brooklyn 42
Dallas 42
Roxbury 41
Ho Chi Minh City 35
Nanjing 34
Buffalo 28
Boardman 27
Council Bluffs 27
Turku 27
Des Moines 26
São Paulo 26
Moscow 25
Columbus 24
Hanoi 23
Brussels 22
Jakarta 22
Marseille 22
Santa Clara 22
Frankfurt am Main 21
London 21
Redwood City 21
Denver 20
Warsaw 20
Johannesburg 19
Montreal 19
Falls Church 18
Atlanta 16
Nanchang 16
Paris 16
Princeton 16
San Diego 16
Chennai 15
Chicago 15
Inglewood 15
Naples 15
Orem 15
Rio de Janeiro 15
Guangzhou 14
Tokyo 14
Dong Ket 13
Nuremberg 13
Poplar 12
Changsha 11
Mexico City 11
Phoenix 11
Shanghai 11
Dhaka 10
Figino 10
Lahore 10
Toronto 10
Boston 9
Brasília 9
Brno 9
Tashkent 9
Baghdad 8
Dublin 8
Düsseldorf 8
Hebei 8
Manchester 8
New Delhi 8
San Francisco 8
Santiago 8
Porto Alegre 7
Portsmouth 7
Amsterdam 6
Belo Horizonte 6
Bogotá 6
Dearborn 6
Florence 6
Pune 6
Shenyang 6
Stockholm 6
The Dalles 6
Tianjin 6
Totale 5.566
Nome #
Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia. 255
BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR 252
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia. 225
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing 221
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia 213
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies 211
Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA 202
Lymphoid Enhancer Binding Factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. 202
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia 201
MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32) 199
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia 195
5'RUNX1-3'USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications. 195
Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology. 187
Genomic BCR-ABL1 breakpoint characterization by a multistrategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients 183
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia 180
Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3 178
Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P. 169
BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation? 167
A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia 166
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology 160
ABSOLUTE QUANTIFICATION OF THE PRETREATMENT PML-RARA MOLECULAR TRANSCRIPT DEFINES THE RELAPSE RISK IN ACUTE PROMYELOCYTIC LEUKEMIA 160
RARA and RARG Gene Downregulation Associated with EZH2 Mutation in Acute Promyelocytic-Like Morphology Leukemia 155
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele 154
MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene 150
ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES 146
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house. 144
Altered gene expression encoding cytochines, grow factors and cell cycle regulators in the endometrium of women with chronic endometritis 141
Chronic Myeloid Leukemia with Variant t(9;22) Shows Dysregulated Expression of Genes Included in Pivotal Cellular Pathways 141
DROPLET DIGITAL PCR ANALYSIS FOR DIAGNOSIS AND MINIMAL RESIDUAL DISEASE MONITORING IN ADULT PH plus ACUTE LYMPHOBLASTIC LEUKEMIA 140
STAT5B GENE DYSREGULATION CORRELATES WITH LEF1 GENE EXPRESSION IN ADULT ACUTE PROMYELOCYTIC LEUKEMIA 140
Identification of novel LTR retrotransposons in the genome of Aedes aegypti 135
Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link? 133
The Behavior of Cytogenetic/Molecular Markers Associated with JAK2 Mutation Status Before and After Primary Myelofibrosis Progression Supports the Hypothesis of the Leukemic Clone's Independence From the JAK2 Mutation 132
Droplet Digital PCR Analysis for Diagnosis and Minimal Residual Disease Monitoring in Adult Ph plus Acute Lymphoblastic Leukemia 126
A novel t(3;9)(q21.2; p24.3) associated with SMARCA2 and ZNF148 genes rearrangement in myelodysplastic syndrome 122
Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia 122
Factors Affecting the Quality of Bacterial Genomes Assemblies by Canu after Nanopore Sequencing 121
Epitranscriptomics in normal and malignant hematopoiesis 117
null 115
Identification and Characterisation of pST1023 A Mosaic, Multidrug-Resistant and Mobilisable IncR Plasmid 110
Evidence of the physical interaction between rpl22 and the transposable element doc5, a heterochromatic transposon of drosophila melanogaster 107
IRF4 expression is low in Philadelphia negative myeloproliferative neoplasms and is associated with a worse prognosis 100
Genome characterization and CRISPR-Cas9 editing of a human neocentromere 98
Nanopore targeted sequencing for rapid gene mutations detection in acute myeloid leukemia 98
IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater? 96
Centromeric fragment of chromosome 7 in atypical chronic myeloid leukemia with the SET binding protein 1 gene mutation. 96
Optical Genome Mapping as a Tool to Unveil New Molecular Findings in Hematological Patients with Complex Chromosomal Rearrangements 95
TNFRSF13B gene mutation in familial acute myeloid leukemia: A new piece in the complex scenario of hereditary predisposition? 95
JAK2 V617f in chronic myeloid leukemia: driving force or passive bystander? 95
null 95
Droplet digital PCR assay for quantifying of CALR mutant allelic burden in myeloproliferative neoplasms 91
Nanopore sequencing sheds a light on the FLT3 gene mutations complexity in acute promyelocytic leukemia 90
Heterochromatin protein 1 interacts with 5′UTR of transposable element ZAM in a sequence-specific fashion 90
The Ribosomal Protein RpL22 Interacts In Vitro with 5′-UTR Sequences Found in Some Drosophila melanogaster Transposons 90
Nanopore Sequencing in Blood Diseases: A Wide Range of Opportunities 89
Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event 87
null 87
Monitoring minimal residual disease by ddPCR in acute lymphoblastic leukemia associated with the FGFR1 gene rearrangement 86
The Role of NLRP3, a Star of Excellence in Myeloproliferative Neoplasms 82
IRF4 Gene Expression on the Trail of Molecular Response: Looking at Chronic Myeloid Leukemia from Another Perspective 80
null 73
The genomic analysis brings a new piece to the molecular jigsaw of idiopathic erythrocytosis 67
Systemic Mastocytosis With Associated Chronic Lymphocytic Leukemia: A Matter Of Diseases Or Prognostic Factors 67
IRF4 dysregulation in chronic myelomonocytic leukemia: another brick in the wall of myelodysplastic/myeloproliferative neoplasms 64
Third-Generation Sequencing in Clinical Practice: The New Era of Precision Medicine? 63
null 58
Venetoclax-based treatment in acute myeloid leukemia: an unexpected bonus on the path to allogeneic hematopoietic stem cell transplant? 51
null 29
Splenomegaly in de novo acute myeloid leukemia is associated with ASXL1 mutations together with a distinct clinical and gene expression profile 10
RUNX1A isoform is overexpressed in acute myeloid leukemia and is associated with FLT3 internal tandem duplications 7
Totale 9.001
Categoria #
all - tutte 34.351
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.351


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022396 27 33 5 9 14 38 18 37 34 33 59 89
2022/2023752 74 123 48 54 89 94 14 88 125 7 14 22
2023/2024419 26 51 20 29 42 147 10 15 0 15 11 53
2024/20251.422 85 19 62 89 70 96 218 151 30 112 194 296
2025/20263.321 441 125 207 412 497 177 290 81 381 315 102 293
2026/202772 72 0 0 0 0 0 0 0 0 0 0 0
Totale 9.001